Lamb Weston reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of 87 cents per share.
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
2d
TipRanks on MSNFresenius Medical Care Secures €1.1 Billion Through Bond IssuanceFresenius Medical Care ( ($FMS) ) has shared an announcement. On April 1, 2025, Fresenius Medical Care successfully placed bonds totaling €1.1 ...
Fresenius, Danone and Proximus benchmarks shake off tariff turmoil â—† Range of new issue concessions needed â—† High orderbook attrition for those pushing hard on spread ...
A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
2d
Zacks Investment Research on MSN5 Relative Price Strength Stocks to Navigate Today's MarketThe U.S. stock market took a wild ride in the first quarter of 2025, as the S&P 500 notched its biggest quarterly loss in nearly three years. Market sentiment suffered a blow as President Trump’s ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
With this in mind, we will now have a look at the 8 Most Undervalued Healthcare Stocks To Buy According To Analysts. For our ...
On March 26, 2025, the FDA approved Fresenius Kabi’s denosumab biosimilars, CONEXXENCE® (denosumab-bnht) and BOMYNTRA® (denosumab-bnht), ...
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results